News|Articles|August 18, 2023
Further Discussion on Plasmids to Establish Release Specifications Using a Risk-Based Approach to Manage Supply (Aug 2023)
Author(s)Eurofins
A panel of experts from bio/pharmaceutical companies discuss plasmids to establish specifications using a risk-based approach to manage supply, including the response to cell & gene therapy industry feedback, future outlook and re-evaluating plasmid risks.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Audits, Inspections, and CDMOs
3
Ready or Not: Biopharma Alignment for CNPV’s Rapid Review
4
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
5
